|
1.
|
Abdel-Rahman EM, Saadulla L, Reeves WB, Awad AS. Therapeutic modalities in diabetic nephropathy: standard and emerging approaches. J Gen Intern Med. 2012 Apr; 27(4):458-68.
|
|
|
|
|
2.
|
Morris SM, Gao T, Cooper TK, Kepka-Lenhart D, Awad AS. Arginase-2 mediates diabetic renal injury. Diabetes. 2011 Nov; 60(11):3015-22.
|
|
|
|
|
3.
|
Awad AS, Kinsey GR, Khutsishvili K, Gao T, Bolton WK, Okusa MD. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol. 2011 Dec; 301(6):F1358-66.
|
|
|
|
|
4.
|
Awad AS, Rouse MD, Khutsishvili K, Huang L, Bolton WK, Lynch KR, Okusa MD. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011 May; 79(10):1090-8.
|
|
|
|
|
5.
|
Awad AS, Rouse M, Huang L, Vergis AL, Reutershan J, Cathro HP, Linden J, Okusa MD. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int. 2009 Apr; 75(7):689-98.
|
|
|
|
|
6.
|
Jo SK, Bajwa A, Ye H, Vergis AL, Awad AS, Kharel Y, Lynch KR, Okusa MD. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int. 2009 Jan; 75(2):167-75.
|
|
|
|
|
7.
|
Jo SK, Bajwa A, Awad AS, Lynch KR, Okusa MD. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int. 2008 Jun; 73(11):1220-30.
|
|
|
|
|
8.
|
Awad AS, Rouse M, Liu L, Vergis AL, Rosin DL, Linden J, Sedor JR, Okusa MD. Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol. 2008 Jan; 19(1):59-68.
|
|
|
|
|
9.
|
Awad AS, Okusa MD. Distant organ injury following acute kidney injury. Am J Physiol Renal Physiol. 2007 Jul; 293(1):F28-9.
|
|
|
|
|
10.
|
Sharma AK, Fernandez LG, Awad AS, Kron IL, Laubach VE. Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2007 Jul; 293(1):L105-13.
|
|
|
|
|
11.
|
Sevigny CP, Li L, Awad AS, Huang L, McDuffie M, Linden J, Lobo PI, Okusa MD. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunol. 2007 Apr 1; 178(7):4240-9.
|
|
|
|
|
12.
|
Awad AS, Ye H, Huang L, Li L, Foss FW, Macdonald TL, Lynch KR, Okusa MD. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol. 2006 Jun; 290(6):F1516-24.
|
|
|
|
|
13.
|
Awad AS, Huang L, Ye H, Duong ET, Bolton WK, Linden J, Okusa MD. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol. 2006 Apr; 290(4):F828-37.
|
|
|
|
|
14.
|
Awad AS, Webb RL, Carey RM, Siragy HM. Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats. Am J Hypertens. 2005 Apr; 18(4 Pt 1):544-8.
|
|
|
|
|
15.
|
Awad AS, Webb RL, Carey RM, Siragy HM. Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade. J Hypertens. 2004 Aug; 22(8):1571-7.
|
|
|
|
|
16.
|
Kalantarinia K, Awad AS, Siragy HM. Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int. 2003 Oct; 64(4):1208-13.
|
|
|
|
|
17.
|
Siragy HM, Awad A, Abadir P, Webb R. The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats. Endocrinology. 2003 Jun; 144(6):2229-33.
|
|
|
|